Sartorius Stedim Biotech SA / Key word(s): Expansion Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France 17-Jun-2025 / 16:00 CET ...

Full transcript - Sartorius Stedim Biotech SA (DIM) Q1 2025: Conference Operator: Ladies and gentlemen, welcome to the Sartorius and Sartorius Treading Biotech Conference Call on the First Quarter ...

Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, started the fiscal year 2025 with a strong first quarter and achieved double-digit profitable growth in sales revenue.

Sartorius Stedim Biotech SA (DIM), with a market capitalization of $135.93 million, reported robust earnings for the first quarter of 2025, exceeding analyst expectations with an earnings per ...

Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: Information on Document Availability 17-Feb-2025 / 10:56 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The ...

Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL 02-Jun-2025 / 11:09 CET/CEST ...

In a challenging environment, Sartorius Stedim Biotech, a leading provider of innovative technologies for the manufacture of biologics, closed the fiscal year with a solid performance. With sales ...

Shares in Sartorius jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a cautious outlook for 2025.

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed ...

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed ...

French biopharmaceutical company Sartorius Stedim Biotech has announced the opening of its new centre for bioprocessing innovation in Marlborough, Massachusetts, US.